Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number ADA583043
Title Targeted Approach to Overcoming Treatment Resistance in Advanced Prostate Cancer.
Publication Date Jul 2013
Media Count 24p
Personal Author K. Scarpinato
Abstract The purpose of this project is to determine if rescinnamine is effective against prostate cancer and treatment resistance. We found that rescinnamine is less effective against prostate cancer that against cancers from other organs. In organisms, the concentration that would effectively cause tumor growth inhibition is limited by its hypotensive activity. We are currently exploring rescinnamine derivatives that have decreased hypotensive activity, and increased tumor growth inhibition.
Keywords Growth(Physiology)
Hypotension
Inhibition
Neoplasms
Prostate cancer
Resistance

 
Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author Georgia Southern Univ., Statesboro. Engineering Studies Program.
Document Type Technical report
Title Note Annual rept.
NTIS Issue Number 1401
Contract Number W81XWH-11-1-0516

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader